The development and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) are strictly regulated by cytokines. Here we show that transforming growth factor-beta (TGF-beta) and interleukin-4 (IL-4) play a crucial and antagonistic role in the development of Tregs. Additionally, these cytokines also have distinct effects on the maintenance of natural (nTregs) and antigen-induced (iTregs) Tregs. Using double-staining and tracking of proliferation of purified and carboxyflourescein succinimidyl ester (CFSE)-labelled mouse T-cell subpopulations we demonstrated that CD4(+) CD25(+) Foxp3(+) iTregs develop upon alloantigenic stimulation in the presence of TGF-beta exclusively from CD4(+) CD25(-) Foxp3(-) precursors. Both the induction of Foxp3 expression and Treg proliferation were prevented when the cells were stimulated in the presence of IL-4. By contrast, nTregs did not proliferate in the presence of the antigen and TGF-beta, and partially lost their Foxp3 expression. IL-4 not only prevented the development of iTregs, but also down-regulated the level of Foxp3 mRNA and decreased the number of Foxp3(+) cells in a population of iTregs. Further analyses proved that IL-4 decreased the expression of Foxp3 only in a population of iTregs, whereas it substantially supported the survival of nTregs. Functional experiments showed that Tregs induced in the presence of alloantigen and TGF-beta inhibited, on a per-cell basis, cell proliferation comparably to nTregs, and their suppressive capacity was not modulated by IL-4. These data suggest that TGF-beta and IL-4 differentially regulate the development of Tregs and distinctly sustain Foxp3 expression and the number of nTregs and iTregs, but have no influence on the suppressive activity of Tregs on a per-cell basis.

Institute of Molecular Genetics Academy of Sciences Videnska Prague Czech Republic

Zobrazit více v PubMed

Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunological self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–52. PubMed

Baumgart M, Tompkins F, Leng J, Hesse M. Naturally occuring CD4+ Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol. 2006;176:5374–87. PubMed

Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med. 2007;13:108–16. PubMed

Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by transcription factor Foxp3. Science. 2003;299:1057–61. PubMed

Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6. PubMed

Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+ CD25+ T regulatory T cells. Nat Immunol. 2003;4:337–42. PubMed

Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27:68–73. PubMed

Li B, Samanta A, Song X, et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int Immunol. 2007;19:825–35. PubMed

Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT. Critical role of heme oxygenase-1 in Foxp3-mediated immunosuppression. Biochem Biophys Res Commun. 2005;327:1066–9. PubMed

Marson A, Kretschmer K, Frampton GM, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature. 2007;445:931–5. PubMed PMC

Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+ CD25− naive T cells to CD4+ CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med. 2003;198:1875–86. PubMed PMC

Fu S, Zhang N, Yopp AC, et al. TGF-β induces Foxp3+ T-regulatory cells from CD4+ CD25− precursors. Am J Transplant. 2004;4:1614–27. PubMed

Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H. The IL-4 receptor α-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+ CD4+ regulatory T cells from CD25− CD4+ precursors. J Immunol. 2005;175:6107–16. PubMed

Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, Qin FXF. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Nat Acad Sci USA. 2007;104:18169–74. PubMed PMC

Mantel PY, Kuipers H, Boyman O, et al. GATA3-driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 2007;12:2847–61. PubMed PMC

Horwitz DA, Zheng SG, Gray JD. Natural and TGF-beta-induced Foxp3+ CD4+ CD25+ regulatory T cells are not mirror images of each other. Trends Immunol. 2008;29:429–35. PubMed

Feng G, Wood KJ, Bushell A. Interferon-γ conditioning ex vivo generates CD25+ CD62L+ Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues foe cellular therapy. Transplantation. 2008;86:578–89. PubMed

Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003;3:199–210. PubMed

Holan V, Sedlackova K, Ruzickova M. Production of high levels of Th1 and Th2 cytokines in mice with acquired transplantation tolerance. Cell Immunol. 1996;174:7–12. PubMed

Pace L, Puoli C, Doria G. IL-4 modulation of CD25+ CD4+ T regulatory cell-mediated suppression. J Immunol. 2005;174:7645–53. PubMed

Pace L, Rizza S, Palombi C, Brombacher F, Doria G. Cutting Edge: IL-4-induced protection of CD4+ CD25− Th cells from CD25+ CD4+ regulatory T cell-mediated suppression. J Immunol. 2006;176:3900–4. PubMed

Maerten P, Shen C, Bullens DM, Van Assche G, Van Gool S, Geboes K, Rutgeerts P, Ceuppens JL. Effect of interleukin 4 on CD25+ CD4+ regulatory T cell function. J Autoimmun. 2005;25:112–20. PubMed

Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med. 1996;183:2669–74. PubMed PMC

Thorton AM, Shevach EM. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1988;188:287–96. PubMed PMC

Holan V, Pindjakova J, Krulova M, Neuwirth A, Zajicova A, Fric J. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity and l-arginine metabolism. Transplantation. 2006;81:1708–15. PubMed

Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-β induces a regulatory phenotype in CD4+ CD25− T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004;172:5149–53. PubMed

Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussesnzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005;6:1219–27. PubMed

Floess S, Freyer J, Siewert C, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007;5:169–78. PubMed PMC

Bettelli E, Carrier Y, Gao W, Corn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–8. PubMed

Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998;9:745–55. PubMed

Li MO, Sanjabi S, Flavell RA. Transforming growth factor-β controls development, homeostasis and tolerance of T cells by regulatory T cell-dependent and – independent mechanisms. Immunity. 2006;25:455–71. PubMed

Suzuki H, Kündig TM, Furlonger C, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science. 1995;268:1472–6. PubMed

Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201:723–35. PubMed PMC

Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+ CD25+ T cell suppressor function. J Immunol. 2004;172:6519–23. PubMed

de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+ CD25+ regulatory T cell function. Eur J Immunol. 2004;34:2480–8. PubMed

Brandenburg S, Takahashi T, de la Rosa M, et al. IL-2 induces in vivo suppression by CD4+ CD25+ Foxp3+ regulatory T cells. Eur J Immunol. 2008;38:1643–53. PubMed

Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-β maintains suppressor function and Foxp3 expression in CD25+ CD4+ regulatory T cells. J Exp Med. 2005;201:1061–7. PubMed PMC

Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation ex vivo of TGF-β producing regulatory T cells from CD4+ CD25− precursors. J Immunol. 2002;169:4183–9. PubMed

The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population